A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis
Clinical trial NCT02574325 · UNKNOWN
Trial details
- NCT number
- NCT02574325
- Sponsor
- Arisaph Pharmaceuticals Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-10-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.